Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
Pfs25 is a transmission-blocking vaccine candidate for Plasmodium. Here, McLeod et al. analyze the antibody response to Pfs25 in sera from a clinical trial evaluating a Pfs25 vaccine candidate, identify a potent transmission-blocking antibody and determine recognized epitopes on Pfs25.
Main Authors: | Brandon McLeod, Kazutoyo Miura, Stephen W. Scally, Alexandre Bosch, Ngan Nguyen, Hanjun Shin, Dongkyoon Kim, Wayne Volkmuth, Sebastian Rämisch, Jessica A. Chichester, Stephen Streatfield, Colleen Woods, William R. Schief, Daniel Emerling, C. Richter King, Jean-Philippe Julien |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11980-6 |
Similar Items
-
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
by: Stephen W. Scally, et al.
Published: (2017-11-01) -
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
by: Kathleen A. McGuire, et al.
Published: (2017-06-01) -
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45
by: Prasun Kundu, et al.
Published: (2018-10-01) -
Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission.
by: James A Gregory, et al.
Published: (2012-01-01) -
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
by: Wei-Chiao Huang, et al.
Published: (2020-08-01)